Ulcus cruris venosum (UCV) is the most severe form of chronic venous insufficiency and the quality of life of those affected is usually significantly impaired. In the updated s2k guideline published in 2024, the focus was on the prevention of UCV recurrences in addition to the quality of examination and treatment procedures. It is a practice-oriented guideline that combines the different approaches and levels of knowledge of the respective professional groups and offers a practicable treatment concept for UCV.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Prostate Cancer
Intracrine and Metabolic Tumor Adaptation Under Androgen Deprivation
- Alopecia areata in children, adolescents, and adults
New Guideline Classifies the Evidence Base for Topical and Systemic Therapies
- Cardiology and Nutrition
Ultra-Processed Foods and Cardiovascular Risk—The New AHA Position
- Actinic keratoses
Targeted Treatment of Multiple AK Lesions—Balancing Efficacy and Convenience
- Obesity: A Multimodal and Interdisciplinary Approach
New Swiss Clinical Practice Guideline Provides Guidance
- cSCC: Personalizing Treatment Strategies and Follow-up Care Plans
Comprehensive risk stratification is no simple matter: what’s new?
- Baxdrostat – a new class of drugs for treating difficult-to-control hypertension
First Aldosterone Synthase Inhibitor Is Here
- Geriatric Small-Cell Lung Cancer